Mountain View, CA, United States of America

Gregory D Davis

This inventor holds 3 USPTO granted patents. Top assignees: University of Oklahoma, Clontech Laboratories, Inc.. Active years: 1999-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gregory D Davis. Retrieved from https://idiyas.com/inventor/gregory-d-davis-9p0st02a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 113(Granted Patents)


Location History:

  • San Carlos, CA (US) (1999)
  • Mountain View, CA (US) (2001 - 2002)

Company Filing History:


Years Active: 1999-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Gregory D. Davis: Innovator in Polymerase Chain Reaction Technologies

Introduction

Gregory D. Davis is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of methods and kits for polymerase chain reaction (PCR) fidelity assessment. With a total of 3 patents, his work has advanced the understanding and application of PCR technologies.

Latest Patents

One of Gregory D. Davis's latest patents focuses on methods and kits for determining the fidelity of polymerase chain reaction conditions. This invention provides a systematic approach to evaluate the fidelity of PCR conditions by amplifying a template polydeoxyribonucleotide that includes a pseudo restriction endonuclease restriction site. The resultant amplified product is then analyzed for cleavage products, allowing for the determination of PCR fidelity based on the presence or absence of these products. This method is particularly useful for assessing the fidelity of thermostable polymerases under specific PCR conditions.

Another significant patent involves the development of fusion protein systems designed to enhance the soluble cytoplasmic expression of heterologous proteins in Escherichia coli. This invention includes a fusion sequence that combines a carrier protein with a target heterologous peptide or protein. The objective is to improve the purification process of recombinant fusion proteins by preventing their initial expression in insoluble inclusion bodies. This innovation allows for the production of large quantities of soluble peptides or proteins in host cells that typically express limited amounts.

Career Highlights

Gregory D. Davis has worked with esteemed institutions such as the University of Oklahoma and Clontech Laboratories, Inc. His experience in these organizations has contributed to his expertise in biotechnology and patent development.

Collaborations

Throughout his career, Gregory has collaborated with notable individuals, including Roger G. Harrison, Jr. and Helmut Wurst. These collaborations have further enriched his research and innovation efforts.

Conclusion

Gregory D. Davis is a distinguished inventor whose work in PCR technologies and fusion protein systems has made a lasting impact in the field of biotechnology. His innovative approaches continue to influence research and applications in molecular biology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…